NCT01716923View on ClinicalTrials.gov

Study to Assess S303 RBCs and Evaluate Safety and Efficacy in Patients Requiring Transfusion Support of Acute Anemia

PHASE3CompletedINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

July 31, 2014

Study Completion Date

October 31, 2014

Conditions
Focus:Use of S303 RBCs in Patients With Acute Anemia
Interventions
BIOLOGICAL

S-303 Red Blood Cells (RBCs) - Test

BIOLOGICAL

Conventional, untreated red blood cells (RBCs) - Control

Trial Locations (2)

61231

Kerckhoff-Klinic GmbH, Bad Nauheim

Unknown

Klinikum der J.-W.-G.-Universität Frankfurt, Frankfurt

Sponsors

Lead Sponsor

Cerus Corporation
All Listed Sponsors
lead

Cerus Corporation

INDUSTRY